ENL is the EM clinical trials unit, supporting 28 current trials across six departments:
- EM
- Critical Care
- Neurosurgery
- Neurology/Interventional Neurology
- Trauma Surgery
- Neuro-ophthalmology
Trial funding is diverse, coming from NIH/DoD/CDC/NSF and other government agencies, industry sponsors, and non-profit organizations. The ENL is a Neurologic Emergency Treatment Trials (NETT) network hub and also the Strategies to Innovate Emergency Care Clinical Trials Network (SIREN) hub, both of which are NIH-funded.
ENL faculty and staff support multi-center clinical trials through scientific leadership, oversight, and clinical coordinating efforts. Currently, ENL is leading three on-going multi-center clinical trials:
- Early Minimally-invasive Removal of ICH (ENRICH)
- Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS),
- Endovascular Therapy for Low NIHSS Ischemic Strokes (ENDOLOW)
